FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
The U.S. Food and Drug Administration today issued a supplemental approval for Casgevy* (exagamglogene autotemcel) for patients aged 2 years and older with either sickle cell disease (SCD) with recurrent…
Ancestry matters in the cardiac screening of elite footballers
Elite footballers of Black ethnicity show important ancestry-related differences in cardiac adaptation.1 These results were presented today at ESC Preventive Cardiology 2026, the annual congress of the European Association of…